Skip to main content
Retour
Watch Compare

Ginkgo Bioworks Holdings, Inc.

Qualité des données : 100%
Également cotée sous DNABW NYSE
DNA
NYSE Manufacturing Chemicals
6,45 €
▲ 0,02 € (0,31%)
Cap. Boursière: 394,77 M
Prix
6,38 €
Cap. Boursière
394,77 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Revenue declined -14,19% annually over 5 years
Negative free cash flow of -178,72 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 10,87%
Capital efficient — spends only 4,50% of revenue on capex

Croissance

Revenue Growth (5Y)
-14,19%
En dessous de la moyenne du secteur (1,82%)
Revenue (1Y)-25,06%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-53,34%
Au-dessus de la moyenne du secteur (-54,47%)
ROIC-22,56%
Net Margin-183,81%
Op. Margin-185,29%

Sécurité

Debt / Equity
N/A
Current Ratio4,39
Interest CoverageN/A

Valorisation

PE (TTM)
-1,26
Au-dessus de la moyenne du secteur (-1,49)
P/B Ratio0,71
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1385 pairs)
Métrique Action Médiane du Secteur
P/E -1,3 -1,5
P/B 0,7 1,6
ROE % -53,3 -54,5
Net Margin % -183,8 -41,5
Rev Growth 5Y % -14,2 1,8
D/E — 0,3

Objectif de Cours des Analystes

3 analystes
Sell
Actuel
6,45 €
+34.4%
Objectif
8,67 €
5,00 €
9,00 €
12,00 €
Prévisions
BPA Prévisionnel -3,86 €
CA Est. 158,63 M

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 -3,86 €
-4,69 € – -3,03 €
 158,63 M 2
FY2026 -4,39 €
-5,16 € – -3,69 €
 159,40 M 3

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 -1,11 € -0,77 € +30,5%
Q32025 -1,24 € -1,45 € -16,9%
Q22025 -1,57 € -1,10 € +29,8%
Q12025 -1,77 € -1,68 € +5,1%

ETFs Holding This Stock

WDNA WDNA
2,73% weight
CNCR CNCR
2,33% weight
VEGN VEGN
0,14% weight
NXTE logo NXTE AXS Green Alpha ETF
0,09% weight
AVSCX AVSCX
0,04% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0,02% weight
IRSSX IRSSX
0,02% weight
IRCIX IRCIX
0,01% weight
IIRSX IIRSX
0,01% weight
IRSIX IRSIX
0,01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -25,06% Revenue Growth (3Y) -17,74%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -14,19% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 170,16 M Net Income (TTM) -312,76 M
ROE -53,34% ROA -25,85%
Gross Margin N/A Operating Margin -185,29%
Net Margin -183,81% Free Cash Flow (TTM) -178,72 M
ROIC -22,56% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4,39
Interest Coverage N/A Asset Turnover 0,14
Working Capital 390,80 M Tangible Book Value 498,26 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,26 Forward P/E N/A
P/B Ratio 0,71 P/S Ratio 2,32
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 2,49 Fwd Earnings Yield N/A
FCF Yield -45,27%
Market Cap 394,77 M Enterprise Value 283,70 M
Per Share
EPS (Diluted TTM) -5,64 Revenue / Share 2,75
FCF / Share -2,89 OCF / Share -2,76
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 4,50% FCF Conversion 57,14%
SBC-Adj. FCF -253,10 M Growth Momentum -10,87

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 170,16 M 227,04 M 251,46 M 477,71 M 313,84 M
Net Income -312,76 M -547,03 M -892,87 M -2,10 B -1,83 B
EPS (Diluted) -5,64 -10,54 -0,46 -1,25 -1,39
Gross Profit — — — — —
Operating Income -315,28 M -559,76 M -864,41 M -2,21 B -1,83 B
EBITDA — — — — —
R&D Expenses 243,77 M 424,06 M 580,62 M 1,05 B 1,15 B
SG&A Expenses — — — — —
D&A 58,99 M 63,02 M 70,51 M 42,55 M 29,08 M
Interest Expense 0,0 94 000,0 93 000,0 106 000,0 2,37 M
Income Tax -837 000,0 -479 000,0 -71 000,0 -15,03 M -1,48 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1,12 B 1,38 B 1,67 B 2,54 B 2,07 B
Total Liabilities 611,11 M 661,39 M 568,19 M 803,04 M 503,61 M
Shareholders' Equity 508,59 M 716,06 M 1,10 B 1,74 B 1,51 B
Total Debt — — — — —
Cash & Equivalents 167,20 M 561,57 M 944,07 M 1,32 B 1,55 B
Current Assets 471,84 M 602,74 M 1,00 B 1,45 B 1,72 B
Current Liabilities 95,97 M 107,27 M 163,86 M 172,96 M 134,76 M